Alexion Pharmaceuticals, Inc.
USD182.50
+0.00 (+0.00%)
CEO
Ludwig Hantson
IPO Date
1996-02-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$181.04
Prev. Close
$182.50
Day Low
$180.21
Day High
$182.67
52W Low
$99.91
52W High
$187.45
Volume
0.00M
| 10.1 |
| 31 Dec 2018 | FY | 90.9% | 1.9% | 0.8% | 0.6% | 0.31 | 2.88 | 281.7 |
| 31 Dec 2017 | FY | 87.2% | 12.5% | 5.0% | 3.3% | 0.32 | 3.10 | 60.4 |
| 31 Dec 2016 | FY | 91.6% | 12.9% | 4.6% | 3.0% | 0.35 | 3.13 | 68.7 |
| 31 Dec 2015 | FY | 91.0% | 5.5% | 1.7% | 1.1% | 0.42 | 3.38 | 282.0 |
| 31 Dec 2014 | FY | 92.2% | 29.4% | 19.9% | 15.6% | 0.02 | 4.61 | 55.8 |
| 31 Dec 2013 | FY | 88.6% | 16.3% | 10.6% | 7.6% | 0.05 | 3.75 | 102.7 |
| 31 Dec 2012 | FY | 93.6% | 22.5% | 12.9% | 9.7% | 0.08 | 4.15 | 70.1 |
| 31 Dec 2011 | FY | 88.1% | 22.4% | 15.5% | 12.6% | 0.00 | 4.09 | 74.7 |
| 16.0 |
| 30 Sept 2020 | Q3 | 90.9% | 36.4% | 5.2% | 3.3% | 0.23 | 3.81 | 10.8 |
| 30 Jun 2020 | Q2 | 90.0% | -73.9% | -10.2% | -6.4% | 0.23 | 4.79 | -5.8 |
| 31 Mar 2020 | Q1 | 92.3% | 38.6% | 4.7% | 3.1% | 0.21 | 4.35 | 8.9 |
| 31 Dec 2019 | Q4 | 91.7% | 64.2% | 7.9% | 5.1% | 0.22 | 4.25 | 6.7 |
| 30 Sept 2019 | Q3 | 92.5% | 37.0% | 4.5% | 3.2% | 0.24 | 3.98 | 11.7 |
| 30 Jun 2019 | Q2 | 91.8% | 38.2% | 4.5% | 3.2% | 0.25 | 4.04 | 16.0 |
| 31 Mar 2019 | Q1 | 92.5% | 51.6% | 6.1% | 4.2% | 0.27 | 3.87 | 12.9 |
| 31 Dec 2018 | Q4 | 91.4% | -4.0% | -0.5% | -0.3% | 0.31 | 2.88 | -120.7 |